| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8283304 | Journal of the Neurological Sciences | 2009 | 5 Pages |
Abstract
Our pilot data indicate that vitamin B12 levels decreased in this cohort of AD patients putting a substantial percentage at risk of deficiency and reaching deficiency state in a meaningful number of patients. Repeat screening for B12 deficiency after approximately 2Â years of follow-up seems warranted in order to prevent hematological and neurological manifestations that may significantly alter their quality of life.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
C.I. Prodan, L.D. Cowan, J.A. Stoner, E.D. Ross,